Business Description
Albireo Pharma Inc
NAICS : 325412
SIC : 2834
ISIN : US01345P1066
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.31 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.31 | |||||
Beneish M-Score | 1.57 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.7 | |||||
3-Year EBITDA Growth Rate | 33.6 | |||||
3-Year EPS without NRI Growth Rate | 23.4 | |||||
3-Year FCF Growth Rate | -34.8 | |||||
3-Year Book Growth Rate | -4 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | 159.16 | |||||
12-1 Month Momentum % | 66.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.32 | |||||
Quick Ratio | 6.23 | |||||
Cash Ratio | 5.88 | |||||
Days Inventory | 213.7 | |||||
Days Sales Outstanding | 12.38 | |||||
Days Payable | 930.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.4 | |||||
Shareholder Yield % | -0.07 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 95.56 | |||||
Operating Margin % | -214.17 | |||||
Net Margin % | -228.51 | |||||
FCF Margin % | -202.61 | |||||
ROE % | -91.17 | |||||
ROA % | -46.51 | |||||
ROIC % | -257.7 | |||||
ROC (Joel Greenblatt) % | -12424.56 | |||||
ROCE % | -50.68 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 14.93 | |||||
PB Ratio | 9.13 | |||||
Price-to-Tangible-Book | 11.04 | |||||
EV-to-EBIT | -6.03 | |||||
EV-to-EBITDA | -6.05 | |||||
EV-to-Revenue | 12.98 | |||||
EV-to-Forward-Revenue | 12.61 | |||||
EV-to-FCF | -6.41 | |||||
Price-to-Net-Current-Asset-Value | 51.94 | |||||
Price-to-Net-Cash | 735.83 | |||||
Earnings Yield (Greenblatt) % | -16.58 | |||||
FCF Yield % | -13.52 |